Liposarcoma overview: Difference between revisions

Jump to navigation Jump to search
Alejandro Lemor (talk | contribs)
No edit summary
Alejandro Lemor (talk | contribs)
Line 39: Line 39:


=== Laboratory Findings ===
=== Laboratory Findings ===
A biopsy of the liposarcoma will give the definitive diagnosis and the histopathological subtype of liposarcoma.  Other laboratory finding include anemia, due to GI bleeding, and increased [[BUN]] and [[creatinine]] in case of obstructive nephropathy.


=== CT ===
=== CT ===

Revision as of 21:06, 22 September 2014

Liposarcoma Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Liposarcoma from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Study of Choice

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

X-ray

Echocardiography and Ultrasound

CT scan

MRI

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Liposarcoma overview On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Liposarcoma overview

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Liposarcoma overview

CDC on Liposarcoma overview

Liposarcoma overview in the news

Blogs on Liposarcoma overview

Directions to Hospitals Treating Liposarcoma

Risk calculators and risk factors for Liposarcoma overview

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Alejandro Lemor, M.D. [2]; Ammu Susheela, M.D. [3]

Overview

Liposarcoma is a malignant tumor that arises in fat cells in deep soft tissue, such as that inside the thigh or in the retroperitoneum.

They are typically large bulky tumors which tend to have multiple smaller satellites extending beyond the main confines of the tumor.

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Liposarcoma from other Diseases

Liposarcoma must be differentiated from other diseases that cause a painless, growing mass such as spindle cell lipoma, neurofibroma, dermatofibrosarcoma protuberans, and malignant peripheral nerve sheath tumor.

Epidemiology and Demographics

Risk Factors

Natural History, Complications and Prognosis

Liposarcoma may have different clinical presentations depending on the location of the mass, being the lower extremities the most common area involved. Metastasis is the most important aspect to assess in the prognosis of the disease, but the mass may compress adjacent structures causing different clinical manifestations. The prognosis will depend on the histopathological subtype, being the well differentiated liposarcoma the subtype with the best prognosis, and the pleomorphic liposarcoma with the worst prognosis.

Diagnosis

Staging

The staging for liposarcoma is based on the TNM classification, depending on the primary tumor, lymph node involvement, metastasis and the histological grade of the tumor.

History and Symptoms

Liposarcomas usually present as a growing mass, not associated with pain and commonly located in the lower extremities. Retroperitoneal liposarcomas remain asymptomatic until they affect adjacent structures, causing pain or obstructive symptoms.

Physical Examination

The physical examination findings will depend on the location of the liposarcoma, being the most common location the lower extremities. The main finding is a painless, slow growing, firm mass in one of the lower extremities. Retroperitoneal liposarcomas would have a late presentation and the physical examination findings include abdominal tenderness, abdominal distention and weight loss.

Laboratory Findings

A biopsy of the liposarcoma will give the definitive diagnosis and the histopathological subtype of liposarcoma. Other laboratory finding include anemia, due to GI bleeding, and increased BUN and creatinine in case of obstructive nephropathy.

CT

CT imaging is one of the most important tests for the diagnosis of liposarcoma. CT should assess the size, location and depth of the liposarcoma, as well as the lymph node involvement and distant metastasis. CT findings can be correlated with the histopathological subtype.

MRI

MRI is the imaging test of choice for the diagnosis of liposarcoma and should assess size, location and depth of the mass. MRI findings help to differentiate between the different subtypes of liposarcoma and help to assess distant metastasis.

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Cost-Effectiveness of Therapy

Future or Investigational Therapies

References


Template:WikiDoc Sources